Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-15-2024-59166.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-7-2022-68481.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-30-2022-40173.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-2-2021-1622637119.pdf
https://www.fiercepharma.com/manufacturing/acella-facing-43-serious-side-effect-reports-pulls-dozens-lots-sub-potent-thyroid
https://www.prnewswire.com/news-releases/acella-pharmaceuticals-llc-issues-voluntary-nationwide-recall-of-certain-lots-of-np-thyroid-thyroid-tablets-usp-due-to-sub-potency-301280741.html
https://www.pharmacompass.com/pdf/news/acella-pharmaceuticals-llc-issues-recall-np-thyroid15-120-due-to-sub-potency-1600842962.pdf
https://pink.pharmaintelligence.informa.com/PS142873/The-Quality-Lowdown-Warning-Letters-Suggest-How-The-FDA-Set-Priorities-During-COVID19
https://www.pharmacompass.com/pdf/news/acella-pharmaceuticals-receives-fda-warning-letter-1599028049.pdf
https://www.raps.org/news-and-articles/news-articles/2020/9/fda-warns-mylan-acella-pharmaceuticals-over-gmp-vi